UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
September 9, 2025
Accession Number:
0001178913-25-003257
Submission Type:
POS AM
CIK:
0001553846
Company Name:
RedHill Biopharma Ltd.
File Number:
333-276979